Related Experiment Video
Updated: Mar 25, 2026

09:49
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
16.6K
Peridischarge prophylactic platelet transfusions after stem cell transplant: is a tranfusion trigger needed?
Kenneth R Meehan1,2,3, Purva Sharma4,3, Dorothy R McKenna1,2,3
1Blood and Marrow Transplant Program.
Transfusion
|February 13, 2016
Summary
Lowering the prophylactic platelet (PLT) transfusion threshold for transplant recipients could avoid many transfusions. A risk-adapted approach may optimize PLT use before discharge.
Area of Science:
- Hematology
- Transplant Medicine
- Oncology
Background:
- Assessing the appropriateness of peridischarge platelet (PLT) transfusions in transplant recipients.
- Evaluating the feasibility of reducing the PLT transfusion threshold before discharge.
Purpose of the Study:
- To examine the appropriateness of prophylactic PLT transfusions within 24 hours of discharge.
- To determine if lowering the PLT transfusion threshold is feasible in transplant recipients.
Main Methods:
- Retrospective review of prophylactic PLT transfusions administered within 24 hours of discharge.
- Analysis of transfusion indications and adherence to institutional guidelines.
- Identification of 187 transplant patients, with 44 receiving prophylactic PLT transfusions.
Main Results:
- Of 44 patients receiving transfusions, indications included meeting discharge PLT count (20 × 10(9)/L), central venous catheter removal, active bleeding, or anticoagulation.
- 95% of prophylactic PLT transfusions were deemed appropriate; only 5% were avoidable.
- Lowering the threshold to 15 × 10(9)/L could have avoided 41% of appropriate transfusions.
Conclusions:
- A significant portion of prophylactic PLT transfusions before discharge may be avoidable.
- A risk-adapted strategy for selecting transplant recipients for prophylactic PLT transfusions could be beneficial.
- Further research is warranted to explore risk-adapted methods for PLT transfusion management.
Related Concept Videos
Bone Marrow Sampling and Transplants
2.3K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K
Kidney Transplant II: Surgical Procedure
763
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
763
Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K

